BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4055543)

  • 1. Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.
    Adams DH; Wood MJ; Farrell ID; Fox C; Ball AP
    J Antimicrob Chemother; 1985 Sep; 16(3):359-66. PubMed ID: 4055543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.
    Iravani A; Richard GA
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1212-6. PubMed ID: 2802549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up.
    Brumfitt W; Hamilton-Miller JM; Smith GW
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1442-3. PubMed ID: 3674851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections.
    Cooper TJ; Ladusans E; Williams PE; Polychronopoulos V; Gaya H; Rudd RM
    J Antimicrob Chemother; 1985 Sep; 16(3):373-8. PubMed ID: 4055545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children.
    Kornberg AE; Sherin K; Veiga P; Mydlow PK; Collins JJ; Feld LG
    Am J Nephrol; 1994; 14(3):169-72. PubMed ID: 7977475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of cefuroxime-axetil administered by the oral route in the elderly].
    Veyssier P; Darchis JP; Devillers A
    Therapie; 1988; 43 Suppl 4():355-9. PubMed ID: 3222776
    [No Abstract]   [Full Text] [Related]  

  • 7. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.
    Williams PE; Harding SM
    J Antimicrob Chemother; 1984 Feb; 13(2):191-6. PubMed ID: 6706890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil.
    Leigh DA; Joy GE; Tait S; Harris K; Walsh B
    J Antimicrob Chemother; 1989 Feb; 23(2):267-73. PubMed ID: 2708184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women.
    Naber KG; Koch EM
    Infection; 1993; 21(1):34-9. PubMed ID: 8449579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Perry CM; Brogden RN
    Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosing.
    Sommers DK; Van Wyk M; Williams PE; Harding SM
    Antimicrob Agents Chemother; 1984 Mar; 25(3):344-7. PubMed ID: 6721467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
    Williams KJ; Hebblethwaite EM; Brown GW; Cox DM; Plested SJ
    Drugs Exp Clin Res; 1987; 13(2):95-9. PubMed ID: 3556123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.
    Harding SM; Williams PE; Ayrton J
    Antimicrob Agents Chemother; 1984 Jan; 25(1):78-82. PubMed ID: 6703686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
    Iakovlev SV; Suvorova MP; DvoretskiÄ­ LI; Vlasenko NA; Shakhova TV
    Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections.
    Hebblethwaite EM; Brown GW; Cox DM
    Drugs Exp Clin Res; 1987; 13(2):91-4. PubMed ID: 3582135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cefuroxime axetil. An antibiotic advances].
    Fortschr Med Suppl; 1990; 92():4-13. PubMed ID: 2199359
    [No Abstract]   [Full Text] [Related]  

  • 17. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefuroxime axetil: a new oral cephalosporin.
    Drug Ther Bull; 1989 Jan; 27(2):5-7. PubMed ID: 2700699
    [No Abstract]   [Full Text] [Related]  

  • 19. Reassessment of cefuroxime axetil for the treatment of recurrent urinary infections.
    Brumfitt W; Hamilton-Miller JM; al-Wali W
    J Antimicrob Chemother; 1990 Jul; 26(1):161-2. PubMed ID: 2211441
    [No Abstract]   [Full Text] [Related]  

  • 20. Enoxacin relieves symptoms of recurrent urinary infections more rapidly than cefuroxime axetil.
    Brumfitt W; Hamilton-Miller JM; Walker S
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1558-9. PubMed ID: 8363392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.